Govt eases compensation guidelines for clinical trials
DTAB says medical management should be provided if injury is due to clinical trial related activities only
New Delhi: Criticized for drafting what the industry thought were untenable norms for clinical trials, India’s health ministry has blinked and amended guidelines for compensation of participants in trials that go wrong.
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more